Biophytis (EPA:ALBPS) | WebDisclosure

Basculer en Français

11039	Companies
241925	Keywords
170320	Articles
130220	Press releases

Home
Companies
Biophytis

BRIEF

published on 07/29/2026 at 23:05, 1 month 22 days ago

Biophytis Reports Audited 2025 Financial Results and Stock Trading Resumption

Financial Results Biophytis Trading Resumption 2025 Audit Funding Uncertainty
BRIEF

published on 07/29/2026 at 23:05, 1 month 22 days ago

Biophytis : Publication des comptes annuels 2025 et reprise de la cotation

Biophytis Trésorerie Cotation Boursière Incertitude Financière Résultats Financiers 2025
REGULATED PRESS RELEASE

published on 07/29/2026 at 23:00, 1 month 22 days ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% compared to 2024

Financial Statements Biophytis Financial Debt Trading Resumption Liabilities
REGULATED PRESS RELEASE

published on 07/29/2026 at 23:00, 1 month 22 days ago

Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action
Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de sa cotation sur Euronext Growth Paris. Les résultats financiers montrent une amélioration malgré une perte nette de 8,2 M€

Résultats Financiers Biophytis Cotation Comptes Annuels Perte Nette
PRESS RELEASE

published on 07/29/2026 at 22:59, 1 month 22 days ago

Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action
Biophytis annonce la publication de ses comptes annuels 2025 et la reprise de la cotation de son action sur Euronext Growth Paris. Les résultats financiers et opérationnels sont présentés ainsi que la situation de trésorerie

Résultats Financiers Euronext Growth Paris Biophytis Trésorerie Comptes Annuels
PRESS RELEASE

published on 07/29/2026 at 22:59, 1 month 22 days ago

BIOPHYTIS ANNOUNCES THE AUDITING OF ITS 2025 FINANCIAL STATEMENTS AND THE RESUMPTION OF TRADING IN ITS STOCK
Biophytis announces the auditing of its 2025 financial statements and the resumption of trading in its stock. The company's financial debt and current liabilities decreased by 5% in 2025. Net loss improved by 13% compared to 2024

Financial Statements Biophytis Trading Net Loss Financial Debt
BRIEF

published on 07/01/2026 at 07:05, 2 months 20 days ago

Biophytis Reports 2025 Financial Outcomes and Strategic Plans

Regulatory Milestones Asian Joint Venture Biophytis Financial Results Sarcopenia Clinical Trials Cash Flow Uncertainty
BRIEF

published on 07/01/2026 at 07:05, 2 months 20 days ago

Biophytis : Résultats financiers provisoires 2025 et nouvelles stratégies

Résultats Financiers Biophytis Sarcopénie Continuité D'exploitation Joint-venture Asie
REGULATED PRESS RELEASE

published on 07/01/2026 at 07:00, 2 months 20 days ago

Biophytis communique ses résultats financiers provisoires et partage ses perspectives stratégiques
Biophytis communique ses résultats financiers provisoires pour l'exercice 2025 et partage ses perspectives stratégiques, incluant des avancées dans la sarcopénie et l'obésité

Résultats Financiers Biophytis Sarcopénie Obésité Perspectives Stratégiques
REGULATED PRESS RELEASE

published on 07/01/2026 at 07:00, 2 months 20 days ago

BIOPHYTIS REPORTS ITS PROVISIONAL FINANCIAL RESULTS AND PROVIDES ITS STRATEGIC OUTLOOK
Biophytis reports provisional financial results for fiscal year 2025 and strategic outlook, including milestones in sarcopenia and obesity programs, engagement with scientific community, and financial restructuring

Biophytis Sarcopenia Obesity Strategic Outlook Provisional Financial Results

Accesswire

Published on 09/21/2026 at 15:45, 35 minutes ago

Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 2 hours ago

Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 2 hours 15 minutes ago

Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 2 hours 20 minutes ago

Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 13:45, 2 hours 35 minutes ago

Nine Mile Metals DDH WD-26-11 Intersects 2 High Grade VMS Zones Over 27.6M Including 3.08% CU-EQ Over 10.70M, 3.27% CU-EQ Over 9.30M and 4.30% CU-EQ Over 5.0M

View all ACCESSWIRE

EQS Group

Published on 09/21/2026 at 16:08, 11 minutes ago

EQS-Adhoc: EPH Group AG: Purchase agreements signed for the acquisition of an approximately 26,363 m² property in Burgenland
Published on 09/21/2026 at 16:02, 17 minutes ago

Press release: Leonteq publishes results of the EGM 2026
Published on 09/21/2026 at 15:36, 43 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Prologis, Inc.
Published on 09/21/2026 at 15:35, 44 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Permanent TSB Group Holdings plc
Published on 09/21/2026 at 15:35, 44 minutes ago

Hg extends collaboration with Anthropic to bring agentic AI capabilities across the portfolio

Les Echos

Published on 09/21/2026 at 07:00, 9 hours 20 minutes ago

Peugeot Invest takes a stake in Mérieux NutriSciences
Published on 09/21/2026 at 07:00, 9 hours 20 minutes ago

Peugeot Invest entre au capital de Mérieux NutriSciences
Published on 09/18/2026 at 18:34, 2 days 21 hours ago

Disclosure of transactions in own shares from September 14 to September 18, 2026
Published on 09/18/2026 at 18:34, 2 days 21 hours ago

Déclaration hebdomadaire d'opérations effectuées du 14 au 18 septembre 2026
Published on 09/18/2026 at 18:10, 2 days 22 hours ago

Rapport semestriel 2026

View all LES ECHOS COMFI WIRE